Cell Signaling Market Strategic Assessment & SWOT Analysis and Forecast To 2027 – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Posted April 14th, 2021 for Datalogic
The compactness of a smart camera with the power of a vision system
Bologna , April 14
th , 2021. Datalogic, a global leader in the automatic data capture and factory automation markets, is pleased to announce the P2X series, the ultimate smart camera with the unparalleled performance and flexibility of the most innovative vision system. Although very technically capable, the P2X is easily setup and operated. The heavyweight specifications packed into the industrial-grade camera housing will let operators tackle the most demanding of application requirements. The small form factor and large field of view make it the ideal camera on robot guidance applications. The powerful and feature-rich built-in lighting system is designed to be used on production lines for materials of all shapes, sizes and colors. The benefits are endless, and it is undeniable that the new P2X series from Datalogic is a far superior smart camera to all othe
Cannabis compound inhibits SARS-CoV-2 replication in human lung cells
Researchers in the United States have conducted a study showing that a cannabis plant compound inhibited infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells.
SARS-CoV-2 is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that continues to sweep the globe posing a threat to global public health and the worldwide economy.
Marsha Rosner from the University of Chicago in Illinois and colleagues found that cannabidiol (CBD) and its metabolite 7-OH-CBD potently blocked SARS-CoV-2 replication in lung epithelial cells.
The CBD inhibited viral gene expression and reversed many of the effects the virus has on host gene transcription.
Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.
Researchers confirm new drug development route for treating multiple sclerosis, asthma
Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.
The venomous toadfish Thalassophryne nattereri contains a peptide (TnP) with anti-inflammatory and anti-allergic potential. Confirmation of this potential has now come via the zebrafish Danio rerio, a popular aquarium species native to South Asia that shares 70% of its genome with humans and is widely used as a model for in vivo trials in drug development.
The researchers tested TnP in D. rerio to measure its toxicity. In a little over a year, their research showed that the peptide is safe. It did not cause cardiac dysfunction or neurological problems in the toxicity tests they performed.